HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Evan's syndrome

Also Known As:
Autoimmune hemolytic anemia and autoimmune thrombocytopenia; Evan syndrome
Networked: 47 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Patsouris, Efstratios: 2 articles (08/2012 - 06/2010)
2. Korkolopoulou, Penelope: 2 articles (08/2012 - 06/2010)
3. Mishra, Vikas A: 1 article (01/2015)
4. Sharma, Akhilesh: 1 article (01/2015)
5. Sadeghi, Edris: 1 article (01/2015)
6. Payandeh, Mehrdad: 1 article (01/2015)
7. Sadeghi, Masoud: 1 article (01/2015)
8. Shivalingaiah, Savitha Keelara: 1 article (01/2015)
9. Harbada, Rishit: 1 article (01/2015)
10. Jain, M Karthik: 1 article (01/2015)

Related Diseases

1. Thrombocytopenia (Thrombopenia)
2. Anemia
3. Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
4. Hemolytic Anemia
5. Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/01/2012 - "Based on these data, we initially suspected Evan's syndrome, which involves idiopathic thrombocytopenic purpura with autoimmune hemolytic anemia. "
12/01/1995 - "Evan's syndrome is a hematologic disorder characterized by autoimmune thrombocytopenia and autoimmune hemolytic anemia. "
11/01/1991 - "21 patients with chronic idiopathic thrombocytopenic purpura (ITP) and 3 patients with Evan's syndrome underwent partial splenic embolization (PSE). "
03/01/2011 - "Diagnosis of AID was autoimmune hemolytic anemia (AIHA) in 26 (54%), autoimmune thrombocytopenia (AITP) in 9 (18.8%), Evan's syndrome in 8 (16.7%) and pure red cell aplasia (PRCA) in 5 patients (10.5%). "
06/01/2010 - "The authors report on a rare case of the plasma cell variant of Castleman's disease associated with autoimmune haemolytic anaemia and autoimmune thrombocytopenia (Evan's syndrome) and complicated by mixed nephrotic-nephritic syndrome and acute renal failure due to an underlying glomerulopathy with microscopic and immunofluorescence findings suggestive of membranoproliferative glomerulonephritis (MPGN) type I. Immunocomplexed glomerulonephritis is rare in Castleman's disease, while, to the best of our knowledge, constellation of all these autoimmune phenomena is reported for the first time suggesting that apart from the putative role of VEGF and IL-6 in the pathogenesis of the disease, a more generalised immunological disturbance occurs, probably through autoantibodies induced by active polyclonal B cells raised from Castleman's disease tumour."

Related Drugs and Biologics

1. Inosine Triphosphate (ITP)
2. Autoantibodies
3. Evan's syndrome
4. thymidine 5'-triphosphate (TTP)
5. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
6. Interleukin-6 (Interleukin 6)
7. Vitamin B 12 (Cyanocobalamin)
8. Immunoglobulin G (IgG)
9. Folic Acid (Vitamin M)
10. Danazol (Azol)

Related Therapies and Procedures

1. Splenectomy